To evaluate & compare in vivo safety and efficacy of a skin care formulations in terms of reduction in acne (live/occurring), reduction in acne PIH & sebum content on healthy female subjects - NI

AVT Natural Products Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年6月24日

试验速览

暂无简介。

•1)Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
•2)Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
•3)Having mild to moderate acne 4)Facial skin and sebum level of forehead more than 100 µg/cm2 5)Having acne PIH dark spots

•1)Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
•2)Having refused to give her/his assent by signing the consent form.
•3)Taking part in another study liable to interfere with this study.
•4)Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months).
•5)Being asthmatic.
•6)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex.
•7)Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
•8)Having cutaneous hypersensitivity.
•9)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.10)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
•11)Having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.
•12)Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted).
•13)Subjects receiving steroids or antihistamine medications or receiving isotretinoin for treating other conditions.

发起方

AVT Natural Products Ltd